Internal Medicine, Pulmonary Disease · Charleston, SC
NPI
1043626641
Since 2014
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
171 Ashley Ave
Charleston, SC, 29425
Phone (843) 792-6200
Groups this clinician bills Medicare through
Medicare paid, 2024
$75K
1,085 services
Medicare patients, 2024
436
Average age 72
Drug cost, 2024
$11.9M
3,344 prescriptions
Company payments, 2025
$43K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Denise G Sese was code 99291 (critical care e&m), 174 times for 72 patients. In total Denise G Sese billed 1,085 services in 30 codes, and Medicare paid $75K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 174 | 72 | $155.59 | $27K |
| 99215 Office E&M - Established | Office | 141 | 90 | $121.54 | $17K |
| 99215 Office E&M - Established | Facility | 103 | 67 | $99.66 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 86 | 63 | $12.37 | $1,063 |
| 94010 Pulmonary Function Testing | Facility | 79 | 77 | $6.02 | $476 |
| 99233 Hospital E&M - Subsequent | Facility | 63 | 45 | $87.71 | $5,526 |
| 94010 Pulmonary Function Testing | Office | 55 | 55 | $6.80 | $374 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 55 | 41 | $12.13 | $667 |
| 94729 Pulmonary Function Testing | Facility | 50 | 50 | $6.55 | $327 |
| 94729 Pulmonary Function Testing | Office | 50 | 50 | $8.32 | $416 |
| 94618 Pulmonary Function Testing | Facility | 41 | 39 | $15.69 | $643 |
| 99221 Hospital E&M - Initial | Facility | 29 | 29 | $61.80 | $1,792 |
| 94618 Pulmonary Function Testing | Office | 28 | 28 | $16.01 | $448 |
| 99205 Office E&M - New | Office | 14 | 14 | $152.70 | $2,138 |
| 94726 Pulmonary Function Testing | Office | 13 | 13 | $16.03 | $208 |
By year: 2022 $85K for 1,084 services; 2023 $79K for 1,012 services; 2024 $75K for 1,085 services.
Medicare prescription drug claims, 2024
In 2024, the drug Denise G Sese prescribed most often to Medicare patients was Tadalafil, with 587 prescriptions and refills. In total Denise G Sese wrote 3,344 Medicare prescriptions that cost $11.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tadalafil Generic | 587 | 603 | 66 | $552K |
| Ambrisentan Generic | 331 | 343 | 41 | $1.1M |
| Jardiance Empagliflozin | 209 | 247 | 39 | $141K |
| Furosemide Generic | 175 | 327 | 59 | $634 |
| Spironolactone Generic | 162 | 258 | 34 | $1,479 |
| Sildenafil Citrate Generic | 158 | 177 | 25 | $39K |
| Adempas Riociguat | 157 | 157 | 20 | $2.1M |
| Uptravi Selexipag | 110 | 110 | Under 11 | $2.6M |
| Tyvaso Dpi Treprostinil | 99 | 99 | Under 11 | $2.5M |
| Eliquis Apixaban | 91 | 115 | 16 | $67K |
| Opsumit Macitentan | 72 | 72 | Under 11 | $913K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 68 | 74 | 32 | $1,842 |
| Advair Hfa Fluticasone Propion/Salmeterol | 68 | 82 | 18 | $33K |
| Montelukast Sodium Generic | 55 | 93 | 14 | $406 |
| Potassium Chloride Generic | 54 | 96 | 19 | $857 |
Brand drugs: - claims; generic drugs: 2,057 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Denise G Sese $43K ($43K in general payments such as food, travel and fees) from 7 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $26K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.